Role of canonical Wnt signaling in endometrial carcinogenesis (Q37965633)

26 August 2017

Role of canonical Wnt signaling in endometrial carcinogenesis (English)

1 reference

26 August 2017

1 reference

Thanh H Dellinger

1

1 reference

26 August 2017

Kestutis Planutis

series ordinal

2

1 reference

26 August 2017

Krishnansu S Tewari

series ordinal

3

1 reference

26 August 2017

Randall F Holcombe

series ordinal

4

1 reference

26 August 2017

1 January 2012

1 reference

Expert Review of Anticancer Therapy

26 August 2017

1 reference

26 August 2017

12

1 reference

26 August 2017

1

1 reference

26 August 2017

51-62

1 reference

26 August 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Systemic therapy for recurrent endometrial cancer: a review of North American trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Generation and characterization of dickkopf3 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Promoter methylation of SFRPs gene family in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

New aspects of Wnt signaling pathways in higher vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

A member of the Frizzled protein family mediating axis induction by Wnt-5A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Xenopus frizzled 7 can act in canonical and non-canonical Wnt signaling pathways: implications on early patterning and morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Molecular biology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

A new nuclear component of the Wnt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Pygopus residues required for its binding to Legless are critical for transcription and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

beta-catenin signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The oncogenic activation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

DNA methylation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Commentary: weight gain, weight loss, and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Canonical Wnt signaling is critical to estrogen-mediated uterine growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Differential expression patterns of Wnt and beta-catenin/TCF target genes in the uterus of immature female rats exposed to 17alpha-ethynyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Long-term conservative therapy for endometrial adenocarcinoma in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Progesterone regulation of the endometrial WNT system in the ovine uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

mTOR signaling at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Common corruption of the mTOR signaling network in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Molecular mechanisms of mTOR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Role of the Drosophila patched gene in positional signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

A novel function for Hedgehog signalling in retinal pigment epithelium differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The hedgehog signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Mining the Wnt pathway for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The Wnt/beta-catenin signaling pathway as a target in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Experimental research on the depressant effect of aspirin on Ishikawa adenocarcinoma endometrium cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Aspirin effects on endometrial cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Trans-repression of beta-catenin activity by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.194

Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/CNCR.21649

Identifiers

DOI

10.1586/ERA.11.194

1 reference

26 August 2017

1 reference